Leila Malekmakan

Dr. Leila Malekmakan


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2011 in Scandinavian Journal of Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
PKParviz Khajehdehi
Parviz Khajehdehi
MPMaryam Pakfetrat
Maryam Pakfetrat
KJKatayoun Javidnia
Katayoun Javidnia
FAFariborz Azad
Fariborz Azad
LMLeila Malekmakan
Leila Malekmakan
GDGholamreza Dehghanzadeh
Gholamreza Dehghanzadeh
Objective. End-stage renal disease (ESRD) due to type 2 diabetic nephropathy is a very common condition which is increasing in prevalence, and is associated with high global levels of mortality and morbidity. Both proteinuria and transforming growth factor-β (TGF-β) may contribute to the development of ESRD in patients with diabetic nephropathy. Experimental studies indicate that turmeric improves diabetic nephropathy by suppressing TGF-β. Therefore, this study investigated the effects of turmeric on serum and urinary TGF-β, interleukin-8 (IL-8) and tumour necrosis factor-α (TNF-α), as well as proteinuria, in patients with overt type 2 diabetic nephropathy. Material and methods. A randomized, double-blind and placebo-controlled study was carried out in the Diabetes Clinic of the Outpatient Department of Shiraz University of Medical Sciences on 40 patients with overt type 2 diabetic nephropathy, randomized into a trial group (n = 20) and a control group (n = 20). Each patient in the trial group received one capsule with each meal containing 500 mg turmeric, of which 22.1 mg was the active ingredient curcumin (three capsules daily) for 2 months. The control group received three capsules identical in colour and size containing starch for the same 2 months. Results. Serum levels of TGF-β and IL-8 and urinary protein excretion and IL-8 decreased significantly comparing the pre- and post-turmeric supplementation values. No adverse effects related to turmeric supplementation were observed during the trial. Conclusion. Short-term turmeric supplementation can attenuate proteinuria, TGF-β and IL-8 in patients with overt type 2 diabetic nephropathy and can be administered as a safe adjuvant therapy for these patients.

1 January 2012 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
PKParviz Khajehdehi
Parviz Khajehdehi
BZBatol Zanjaninejad
Batol Zanjaninejad
EAElham Aflaki
Elham Aflaki
MNMohamadAli Nazarinia
MohamadAli Nazarinia
FAFariborz Azad
Fariborz Azad
GDGholam-Reza Dehghanzadeh
Gholam-Reza Dehghanzadeh

31 January 2014 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
MPMaryam Pakfetrat
Maryam Pakfetrat
FBFatemeh Basiri
Fatemeh Basiri
LMLeila Malekmakan
Leila Malekmakan
JRJamshid Roozbeh
Jamshid Roozbeh
Uremic pruritus as a symptom that affects hemodialysis (HD) patients can decrease the quality of life and increase morbidity in these patients. The aim of this study was to evaluate the effects of turmeric on uremic pruritus in HD patients. This was a double-blind placebo-controlled trial conducted on 100 HD patients suffering from pruritus. Patients (mean age 53.3 ± 15.8 years) were randomized into two groups: turmeric and placebo. The pruritus score and biochemical determinants including high-sensitivity C-reactive protein (hs-CRP) were compared before and at the end of the study between the two groups. The mean decrease in hs-CRP was significantly higher in the turmeric than the placebo group (−0.8 ± 2.6 vs. 0.4 ± 8.7 mg/l, p = 0.012). Also reduction of pruritus scores was greater in the turmeric than the placebo group (13.6 ± 2.6 vs. 7.2 ± 2.6, p = 0.001). No side effect was observed during the study due to the use of turmeric. This study demonstrates the possible efficacy of turmeric in decreasing hs-CRP and uremic pruritus in end stage renal disease patients. Future studies are needed to further evaluate the efficacy and safety of turmeric.

27 October 2020 in Andrologia
Verified
Journal Article
Open access
PDF file
AHAbdolreza Haghpanah
Abdolreza Haghpanah
FMFatemeh Masjedi
Fatemeh Masjedi
SASaeed Alborzi
Saeed Alborzi
AHAlireza Hosseinpour
Alireza Hosseinpour
ADAnahita Dehghani
Anahita Dehghani
JRJamshid Roozbeh
Jamshid Roozbeh
The novel coronavirus was recognised in December 2019 and caught humanity off guard. The virus employs the angiotensin‐converting enzyme 2 (ACE2) receptor for entry into human cells. ACE2 is expressed on different organs, which is raising concern as to whether these organs can be infected by the virus or not. The testis appears to be an organ enriched with levels of ACE2, while the possible mechanisms of involvement of the male reproductive system by SARS‐CoV‐2 are not fully elucidated. The major focus of the present studies is on the short‐term complications of the coronavirus and gains importance on studying the long‐term effects, including the possible effects of the virus on the male reproductive system. The aim of this review was to provide new insights into different possible mechanisms of involvement of male gonads with SARS‐CoV‐2 including investigating the ACE2 axis in testis, hormonal alterations in patients with COVID‐19, possible formation of anti‐sperm antibodies (ASA) and subsequently immunological infertility as a complication of SARS‐CoV‐2 infection. Finally, we suggest measuring the sperm DNA fragmentation index (DFI) as a determiner of male fertility impairment in patients with COVID‐19 along with other options such as sex‐related hormones and semen analysis. Invasion of SARS‐CoV‐2 to the spermatogonia, Leydig cells and Sertoli cells can lead to sex hormonal alteration and impaired gonadal function. Once infected, changes in ACE2 signalling pathways followed by oxidative stress and inflammation could cause spermatogenesis failure, abnormal sperm motility, DNA fragmentation and male infertility.

1 January 2006 in Indian Journal of Medical Sciences
Verified
Journal Article
Closed access
MAMehrdad Askarian
Mehrdad Askarian
LMLeila Malekmakan
Leila Malekmakan
Medical, dental, nursing and midwifery students are at high risk for occupational exposure to blood-borne pathogens (BBPs) via sharp injuries such as needle stick injuries (NSIs). The aim of this study was to determine the frequency of NSIs and the knowledge, attitude and practices of these students regarding their prevention. The clinical students at Shiraz University of Medical Sciences, Iran, were eligible to participate in a survey conducted by a self-administered questionnaire in 2004, asking them about NSIs during their clinical training undergraduate years. A cross-sectional study evaluated NSIs and practices regarding protective strategies against BBPs in medical, dental, nursing and midwifery students at Shiraz University, Iran, in 2004. These students completed a self-administered questionnaire. The data were entered into a personal computer using Epi-Info (version 2000). Chi-square and Fisher's exact tests for categorical variables and student t-test for continuous variables were performed, where appropriate, using SPSS version 10. Alpha was set at the 5% level. The questionnaire was completed by 688 (53%) students. 71.1% (489/688) of the students had NSIs that most commonly (43.6%) occurred in patient rooms. 82% (401/489) of NSIs were not reported. 87.8% (604/688) of the students received information about standard isolation precautions and 86.2% of them had been vaccinated against hepatitis B. NSIs and non-reporting of NSIs were highly prevalent in these students. Education about the transmission of blood-borne infections, standard precautions and increasing availability of protection strategies must be provided.

10 January 2009 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MPMaryam Pakfetrat
Maryam Pakfetrat
MNMohammad Hossein Nikoo
Mohammad Hossein Nikoo
LMLeila Malekmakan
Leila Malekmakan
MTMahmood Tabandeh
Mahmood Tabandeh
JRJamshid Roozbeh
Jamshid Roozbeh
PKParviz Khajehdehi
Parviz Khajehdehi